(Total Views: 157)
Posted On: 08/16/2021 3:00:50 PM
Post# of 128126

$LLY News Article - Lilly's lebrikizumab significantly improved skin clearance and itch in people with moderate-to-severe atopic dermatitis in two Phase 3 trials https://marketwirenews.com/news-releases/lill...39117.html


My Twitter: WhyteStocks